Literature DB >> 26083206

Inherited DOCK2 Deficiency in Patients with Early-Onset Invasive Infections.

Kerry Dobbs1, Cecilia Domínguez Conde, Shen-Ying Zhang, Silvia Parolini, Magali Audry, Janet Chou, Emma Haapaniemi, Sevgi Keles, Ivan Bilic, Satoshi Okada, Michel J Massaad, Samuli Rounioja, Adel M Alwahadneh, Nina K Serwas, Kelly Capuder, Ergin Çiftçi, Kerstin Felgentreff, Toshiro K Ohsumi, Vincent Pedergnana, Bertrand Boisson, Şule Haskoloğlu, Arzu Ensari, Michael Schuster, Alessandro Moretta, Yuval Itan, Ornella Patrizi, Flore Rozenberg, Pierre Lebon, Janna Saarela, Mikael Knip, Slavé Petrovski, David B Goldstein, Roberta E Parrott, Berna Savas, Axel Schambach, Giovanna Tabellini, Christoph Bock, Talal A Chatila, Anne Marie Comeau, Raif S Geha, Laurent Abel, Rebecca H Buckley, Aydan İkincioğulları, Waleed Al-Herz, Merja Helminen, Figen Doğu, Jean-Laurent Casanova, Kaan Boztuğ, Luigi D Notarangelo.   

Abstract

Background Combined immunodeficiencies are marked by inborn errors of T-cell immunity in which the T cells that are present are quantitatively or functionally deficient. Impaired humoral immunity is also common. Patients have severe infections, autoimmunity, or both. The specific molecular, cellular, and clinical features of many types of combined immunodeficiencies remain unknown. Methods We performed genetic and cellular immunologic studies involving five unrelated children with early-onset invasive bacterial and viral infections, lymphopenia, and defective T-cell, B-cell, and natural killer (NK)-cell responses. Two patients died early in childhood; after allogeneic hematopoietic stem-cell transplantation, the other three had normalization of T-cell function and clinical improvement. Results We identified biallelic mutations in the dedicator of cytokinesis 2 gene (DOCK2) in these five patients. RAC1 activation was impaired in the T cells. Chemokine-induced migration and actin polymerization were defective in the T cells, B cells, and NK cells. NK-cell degranulation was also affected. Interferon-α and interferon-λ production by peripheral-blood mononuclear cells was diminished after viral infection. Moreover, in DOCK2-deficient fibroblasts, viral replication was increased and virus-induced cell death was enhanced; these conditions were normalized by treatment with interferon alfa-2b or after expression of wild-type DOCK2. Conclusions Autosomal recessive DOCK2 deficiency is a new mendelian disorder with pleiotropic defects of hematopoietic and nonhematopoietic immunity. Children with clinical features of combined immunodeficiencies, especially with early-onset, invasive infections, may have this condition. (Supported by the National Institutes of Health and others.).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26083206      PMCID: PMC4480434          DOI: 10.1056/NEJMoa1413462

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  42 in total

1.  DOCK2 regulates Rac activation and cytoskeletal reorganization through interaction with ELMO1.

Authors:  Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Eiko Iwata; Jens V Stein; Takehiko Sasazuki; Yoshinori Fukui
Journal:  Blood       Date:  2003-06-26       Impact factor: 22.113

Review 2.  Human primary immunodeficiency diseases.

Authors:  Alain Fischer
Journal:  Immunity       Date:  2007-12       Impact factor: 31.745

Review 3.  Human NK cell receptors/markers: a tool to analyze NK cell development, subsets and function.

Authors:  Elisa Montaldo; Genny Del Zotto; Mariella Della Chiesa; Maria Cristina Mingari; Alessandro Moretta; Andrea De Maria; Lorenzo Moretta
Journal:  Cytometry A       Date:  2013-05-06       Impact factor: 4.355

4.  Flow cytometry biomarkers distinguish DOCK8 deficiency from severe atopic dermatitis.

Authors:  Erin Janssen; Erdyni Tsitsikov; Waleed Al-Herz; Gerard Lefranc; Andre Megarbane; Majed Dasouki; Francisco A Bonilla; Talal Chatila; Lynda Schneider; Raif S Geha
Journal:  Clin Immunol       Date:  2013-12-31       Impact factor: 3.969

Review 5.  Dissecting natural killer cell activation pathways through analysis of genetic mutations in human and mouse.

Authors:  Ilaria Tassi; Julia Klesney-Tait; Marco Colonna
Journal:  Immunol Rev       Date:  2006-12       Impact factor: 12.988

Review 6.  Unraveling the functions of plasmacytoid dendritic cells during viral infections, autoimmunity, and tolerance.

Authors:  Melissa Swiecki; Marco Colonna
Journal:  Immunol Rev       Date:  2010-03       Impact factor: 12.988

7.  DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.

Authors:  Yuya Kunisaki; Yoshihiko Tanaka; Terukazu Sanui; Ayumi Inayoshi; Mayuko Noda; Toshinori Nakayama; Michishige Harada; Masaru Taniguchi; Takehiko Sasazuki; Yoshinori Fukui
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

8.  Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells.

Authors:  Erin Janssen; Henner Morbach; Sumana Ullas; Jason M Bannock; Christopher Massad; Laurence Menard; Isil Barlan; Gerard Lefranc; Helen Su; Majed Dasouki; Waleed Al-Herz; Sevgi Keles; Talal Chatila; Raif S Geha; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2014-09-11       Impact factor: 10.793

Review 9.  Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense.

Authors:  Shen-Ying Zhang; Stéphanie Boisson-Dupuis; Ariane Chapgier; Kun Yang; Jacinta Bustamante; Anne Puel; Capucine Picard; Laurent Abel; Emmanuelle Jouanguy; Jean-Laurent Casanova
Journal:  Immunol Rev       Date:  2008-12       Impact factor: 12.988

10.  Guidelines for genetic studies in single patients: lessons from primary immunodeficiencies.

Authors:  Jean-Laurent Casanova; Mary Ellen Conley; Stephen J Seligman; Laurent Abel; Luigi D Notarangelo
Journal:  J Exp Med       Date:  2014-10-13       Impact factor: 14.307

View more
  80 in total

1.  Recurrent viral infections associated with a homozygous CORO1A mutation that disrupts oligomerization and cytoskeletal association.

Authors:  Christina S Yee; Michel J Massaad; Wayne Bainter; Toshiro K Ohsumi; Niko Föger; Andrew C Chan; Nurten A Akarsu; Caner Aytekin; Deniz Çagdas Ayvaz; Ilhan Tezcan; Özden Sanal; Raif S Geha; Janet Chou
Journal:  J Allergy Clin Immunol       Date:  2015-10-21       Impact factor: 10.793

Review 2.  Genomics of Immune Diseases and New Therapies.

Authors:  Michael Lenardo; Bernice Lo; Carrie L Lucas
Journal:  Annu Rev Immunol       Date:  2015-12-23       Impact factor: 28.527

3.  Dedicator of cytokinesis 8 regulates signal transducer and activator of transcription 3 activation and promotes TH17 cell differentiation.

Authors:  Sevgi Keles; Louis Marie Charbonnier; Venkataraman Kabaleeswaran; Ismail Reisli; Ferah Genel; Nesrin Gulez; Waleed Al-Herz; Narayanaswamy Ramesh; Antonio Perez-Atayde; Neslihan E Karaca; Necil Kutukculer; Hao Wu; Raif S Geha; Talal A Chatila
Journal:  J Allergy Clin Immunol       Date:  2016-05-24       Impact factor: 10.793

4.  Mosaic Tetrasomy 9p Associated With Inflammatory Bowel Disease.

Authors:  Luis Sifuentes-Dominguez; Petro Starokadomskyy; Jacob Welch; Bhaskar Gurram; Jason Y Park; Prasad Koduru; Ezra Burstein
Journal:  J Crohns Colitis       Date:  2019-10-28       Impact factor: 9.071

Review 5.  RHO GTPases: from new partners to complex immune syndromes.

Authors:  Rana El Masri; Jérôme Delon
Journal:  Nat Rev Immunol       Date:  2021-02-05       Impact factor: 53.106

Review 6.  Human hyper-IgE syndrome: singular or plural?

Authors:  Qian Zhang; Bertrand Boisson; Vivien Béziat; Anne Puel; Jean-Laurent Casanova
Journal:  Mamm Genome       Date:  2018-08-09       Impact factor: 2.957

Review 7.  Emerging insights into human health and NK cell biology from the study of NK cell deficiencies.

Authors:  Emily M Mace; Jordan S Orange
Journal:  Immunol Rev       Date:  2019-01       Impact factor: 12.988

Review 8.  DOCK8 deficiency: Insights into pathophysiology, clinical features and management.

Authors:  Catherine M Biggs; Sevgi Keles; Talal A Chatila
Journal:  Clin Immunol       Date:  2017-06-15       Impact factor: 3.969

Review 9.  Human inborn errors of immunity to herpes viruses.

Authors:  Emmanuelle Jouanguy; Vivien Béziat; Trine H Mogensen; Jean-Laurent Casanova; Stuart G Tangye; Shen-Ying Zhang
Journal:  Curr Opin Immunol       Date:  2020-01-31       Impact factor: 7.486

10.  Genetic variants of DOCK2, EPHB1 and VAV2 in the natural killer cell-related pathway are associated with non-small cell lung cancer survival.

Authors:  Hailei Du; Lihua Liu; Hongliang Liu; Sheng Luo; Edward F Patz; Carolyn Glass; Li Su; Mulong Du; David C Christiani; Qingyi Wei
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.